PropertyValue
?:abstract
  • The global COVID-19 pandemic has the potential to severely affect those with rheumatic diseases or who are taking immunosuppressive therapies Information is lacking as to how these groups will fare if they become infected A global alliance has rapidly formed to try to address this information deficit
?:creator
?:journal
  • Nature_Reviews_Rheumatology
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Targeting inflammation with collagen-binding antibodies
?:type
?:who_covidence_id
  • #829494
?:year
  • 2020

Metadata

Anon_0  
expand all